In This Section

Continuing Medical Education

Accreditation Statement

The American Association for Cancer Research (AACR) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education activities for physicians.


Credit Designation Statement

AACR has designated this live activity for a maximum of 18.50 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Credit certification for individual sessions may vary, dependent upon compliance with the ACCME Accreditation Criteria. The final number of credits may vary from the maximum number indicated above.

Claiming CME Credit

Physicians and other health care professionals seeking AMA PRA Category 1 Credit(s)TM for this live continuing medical education activity must complete the online CME Request for Credit Survey by Wednesday, February 23, 2022. Certificates will only be issued to those who complete the survey. Your CME certificate will be sent to you via email after the completion of the activity.

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 18.50 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.  

To receive ABIM MOC, participants must request MOC in the CME Request for Credit Survey and complete all questions. Once these steps are completed, AACR will submit your completion information via the ACCME’s Program and Activity Reporting System for the purpose of granting MOC points.

Statement of Educational Need, Target Audience, and Learning Objectives

Metastatic cancer occurs when cancer spreads from the site where the cancer originated to another part of the body. Although metastatic disease can be present at the original diagnosis, often it manifests itself months or decades after treatment. Metastatic disease posses a significant problem and is responsible for 67-90% of tumor-related death. Thus, the majority of tumor-related deaths are due to cancer metastases.

A better understanding of the conditions under which cancer cells become metastatic, accurately determining a patient’s risk for recurrent metastatic disease, and the identifying druggable targets involved in promoting cancer metastases have the potential to significantly reduce cancer mortality.

This conference will provide physicians with a understanding of the latest advances in our understanding of this biological process and outline the clinical implications of these findings in the prevention, detection, and treatment of metastatic cancer. These changes in competence include:

  • Allow physicians to better understand the underlying biology and new approaches to detect and track cancer metastasis.
  • Identify emerging therapeutic approaches to better treat patients with metastatic cancer.
  • To better discuss factors which prevent and promote cancer metastasis.
  • Explain the current research in cancer metastasis

After participating in this CME activity, physicians should be able to:

  1. Discuss the metabolic adaptations that allow and potentiate cancer metastasis.
  2. Identify the impact of genetic instability and signaling on the development of metastatic cells.
  3. Articulate how liquid biopsies can be used to track cancer metastases.
  4. Explain the features of the microenvironment that play a role in the development of metastatic disease .
  5. Compare the genomic and epigenomic changes that occur in metastatic tumors.
  6. Discuss the potential vulnerabilities of circulating tumor cells as an approach to prevent metastases.

Disclosure Statement

It is the policy of the AACR that the information presented at AACR CME activities will be unbiased and based on scientific evidence. To help participants make judgments about the presence of bias, AACR will provide information that Scientific Program Committee members and speakers have disclosed about financial relationships they have with ineligible companies whose primary business is producing , marketing, selling, re-selling, or distributing healthcare products or services used by or on patients. All of the relevant financial relationships for these individuals have been mitigated.

Acknowledgment of Financial or Other Support

This activity is supported by Professional Educational Grants which will be disclosed at the activity.

Questions about CME?

Please contact the Office of CME at (215) 440-9300 or [email protected].